Dr. Eleonora Galosi, MD, is a clinical neurologist and research fellow in the Department of Human Neuroscience at Sapienza University of Rome. Her work focuses on translational research in peripheral neuropathic pain and nociplastic pain. 

Her research integrates advanced clinical, neurophysiological, and molecular phenotyping of peripheral nervous system disorders, with skin biopsy serving as a central methodological pillar. By combining structural nerve fiber biomarkers with functional and clinical measures, Dr. Galosi has contributed to advancing diagnostic strategies and improving the mechanistic understanding of neuropathic and nociplastic pain conditions. 

William Renthal, MD, PhD, is Chief of Headache and Facial Pain in the Department of Neurology at Mass General Brigham and Associate Professor of Neurology at Harvard Medical School. He provides care for patients with refractory headache and facial pain at the John Graham Headache Center. 

Dr. Renthal leads a research laboratory focused on the genomic and epigenomic mechanisms underlying chronic headache and pain. He also directs the Harvard PRECISION Pain Center, a collaborative initiative that brings together clinicians and scientists to apply advanced multi‑omic approaches to identify the cellular drivers of chronic pain using human tissue and patient‑derived samples. 

Dr. Ru‑Rong Ji, PhD, is the William Maixner Professor of Anesthesiology and Director of the Center for Translational Pain Medicine at Duke University Medical Center. His laboratory investigates glial mechanisms of neuropathic pain, with a particular emphasis on neuro–glial interactions following nerve injury and diabetes. His recent work has revealed a critical role for mitochondrial dysfunction in neuropathic pain and has identified multiple therapeutic targets for pain relief and resolution. 

Angelika Lampert, MD, is the Director of the Institute of Neurophysiology at RWTH Aachen University, Germany. She coordinates the Sodium Channel Network Aachen and serves as speaker of the Scientific Center for Neuropathic Pain Aachen (SCNAACHEN), focusing on inherited neuropathic pain syndromes such as small fiber neuropathy linked to sodium channel mutations. Her research emphasizes translational basic science, including patient-derived stem cells, Patch-Seq, sodium channel biophysics, and pharmacology. Angelika is co-chair of the IASP Global Year 2026 on Neuropathic Pain. 

Daniela Maria Menichella, MD, PhD, is an Associate Professor of Neurology and Pharmacology at Northwestern University in Chicago. She directs the Peripheral Neuropathy Multidisciplinary Clinic and the Charcot-Marie-Tooth Association Center for Excellence. Dr. Menichella provides care for patients suffering from neuropathic pain due to peripheral neuropathy. In addition to her clinical work, she is actively involved in basic and translational research and takes part in NIH NeuroNext and NIH HEAL EPICC clinical trials. Her research focuses on the molecular and cellular mechanisms that underlie neuropathic pain and axonal degeneration in both hereditary and acquired peripheral neuropathies, with a particular emphasis on painful diabetic neuropathy. Her laboratory utilizes an integrated approach that combines pain behavioral testing, electrophysiology, in vitro and in vivo calcium imaging, confocal microscopy, chemogenetics, and single-cell RNA sequencing, using conditional and transgenic mouse models. Recently, her lab has begun to validate therapeutic targets using human tissue, such as dorsal root ganglia (DRG) and skin biopsies from patients with well-characterized painful peripheral neuropathies. 

Diana Tavares Ferreira, PharmD, MS, PhD, is Assistant Professor of Neuroscience at the University of Texas at Dallas. She earned her PharmD and MS degrees from the University of Coimbra and completed her PhD in Neuroscience at the University of Sheffield, followed by postdoctoral training at UT Dallas. 

Her research focuses on axonal transport, RNA regulation, and plasticity in neurodegeneration, peripheral neuropathies, and chronic pain. She employs a broad range of omics, experimental, and computational approaches to investigate mechanisms underlying nervous system dysfunction. 

Patrick Dougherty, PhD, is Professor in the Department of Pain Medicine–Research at The University of Texas MD Anderson Cancer Center and Professor in the Department of Neurobiology and Anatomy at The University of Texas Health Science Center at Houston. 

Throughout his career, his research has focused on understanding the neurochemical and physiological consequences of peripheral nerve injury and inflammation on central nervous system activity. His laboratory’s recent work centers on elucidating the mechanisms of pain in cancer patients, with the goal of identifying interventions for chemotherapy‑induced neuropathic pain and cancer‑related hyperalgesia. This work includes complementary clinical and preclinical studies, combining quantitative sensory testing with skin biopsy to define the specific sensory nerve fibers involved in chronic chemoneuropathy.

His research was among the first to demonstrate that cancer itself can contribute to neuropathy prior to treatment and that pre‑existing differences in distal innervation influence pain vulnerability. More recent studies have characterized anatomic, physiological, and transcriptomic changes in human dorsal root ganglia associated with neuropathic pain, revealing sexually dimorphic molecular mechanisms underlying ectopic neuronal activity and persistent pain. 

Dr. Alessandro Chiarotto has a background in physiotherapy (BSc, University of Padua, 2005) and clinical epidemiology (MSc ‘cum laude’, VU University Amsterdam, 2014). During his PhD, he coordinated an international group of researchers, clinicians and patients consumers to develop a core outcome measurement set for clinical trials in patients with low back pain. He completed his PhD in 2018 (VU University Amsterdam) with a thesis entitled “A core outcome measurement set for low back pain”. Since 2018, he works at the Department of General Practice of Erasmus MC. He also works part-time at the VU Department of Health Sciences.

Dr. Chiarotto’s research currently focuses on the clinical management of patients with spine-related musculoskeletal disorders, and on methodological research on the assessment and interpretation of patient-reported outcome measures. He was co-promotor of one PhD student who successfully defended his PhD (2020, Erasmus MC). He now supervises 7 PhD students and one post-doctoral researcher. He has > 40 articles published in international scientific journals (Scopus H-Index 16), including high ranking journals like BMJ, Pain, Journal of Clinical Epidemiology. Two years and half after the end of his PhD, he acquired > 500.000€ in research funding.

Laura A. Frey Law is a Professor of Physical Therapy and Rehabilitation Science at the University of Iowa, where she leads research within the Neuromuscular Biomechanics Laboratory. Her work centers on two major areas of investigation: pain heterogeneity and the dynamics of muscular strength and fatigue.

Dr. Frey Law’s research on pain seeks to understand the multifactorial contributors to individual pain variability, including biological sex, psychological traits, genetics, and activity levels. Utilizing experimental human pain models—such as intramuscular infusion, cold pressor testing, and induced muscle fatigue—along with survey-based measures of pain perception and personality characteristics, she investigates why women appear more likely than men to exhibit referred pain despite similar local pain responses.

Her second line of research focuses on mathematical modeling and empirical study of strength and fatigue, conducted in collaboration with the Virtual Soldier Research group. This work explores static and dynamic strength indices, aging-related differences, sex-based variations, and muscle-specific fatigue patterns to better understand human physical performance capacity and its clinical implications.

Paul W. Hodges DSc MedDr PhD BPhty(Hons) FAA FACP APAM(Hon) is an National Health and Medical Research Council (NHMRC) Leadership Fellow (Level 3), Professor and Director of the Centre for Innovation in Pain and Health Research (CIPHeR) at The University of Queensland (UQ). He is lead chief investigator on an NHMRC Synergy Grant that includes colleagues from the Universities of Queensland, Adelaide and South Australia, and the South Australian Health and Medical Research Institute. Paul is a Fellow of the Australian Academy of Science, which is a Fellowship of the nation's most distinguished scientists, elected by their peers for outstanding research that has pushed back the frontiers of knowledge. He is also a Fellow of the Australian College of Physiotherapists, the Australian Academy of Health and Medical Science, and was made an Honoured member of the Australian Physiotherapy Association, their highest honour.

Stephanie Smith is a researcher within the Pain Centre Versus Arthritis at the University of Nottingham, studying pain management in osteoarthritis knee pain. Stephanie completed a BSc and MRes in Sports and Exercise Science at Nottingham Trent University, followed by a PhD at Glasgow Caledonian University exploring neuromuscular control in knee osteoarthritis. Stephanie then continued working as a post-doc researcher at Glasgow Caledonian University investigating the biomechanics of knee osteoarthritis before joining the University of Nottingham. Her interests lie in bridging the gap between basic science and clinical applications which a particular focus on neuromuscular control, muscle function and pain in osteoarthritis, rheumatic diseases and musculoskeletal conditions. She has also published in phenotyping and ultrasound in osteoarthritis.

Curatolo is professor of Anesthesiology and Pain Medicine at the University of Washington, endowed professor for medical education, and research and director of the interventional pain program. His expertise is in pain management, education and research. Having published over 220 publications, his research focuses on studying nociceptive processes in humans to improve the understanding of pain and facilitate the development of treatments. Curatolo was one of the initiators of the field of ultrasound-guided interventional pain procedures. With an extensive experience in university teaching and mentoring, he has been invited to hold over 300 lectures, courses and workshops in national and international meetings. He has served as reviewer for multiple high ranked scientific journals, funding agencies and external academic institutions.

Luana Colloca is an NIH-funded physician-scientist who conducted ground-breaking studies that have advanced scientific understanding of the psychoneurobiological bases of endogenous systems for pain modulation in humans including the discovery that the vasopressin system is involved in the enhancement of placebo effects with a dimorphic effect. Currently, her team conducts basic and translational research on genomics of orofacial chronic pain, brain mechanisms of expectancy - and observationally-induced hypoalgesia - and immersive virtual reality. Her research has been published in top-ranked international journals including Biological Psychiatry, Pain, Nature Neuroscience, JAMA, Lancet Neurology, Science and NEJM. The impact of her innovative work is clear from her outstanding publications, citation rate, numerous invited lectures worldwide and media featured by The National Geographic, The New Scientist, Washington Post, Boston Globe, The New Yorker, Nature, The Guardian, The Wall Street Journal, News and World Reports.

Dr. Staja “Star” Booker, PhD, RN, FAAN is a tenured Associate Professor at the University of Florida, College of Nursing, widely recognized for her pioneering scholarship on pain disparities, injustices, and health equity. She leads a transformative program of research on the science of pain and aging, advancing understanding of the lived experiences and management of chronic pain among older adults—particularly those who identify as African American/Black. Dr. Booker’s research portfolio is distinguished by multiple NIH-funded studies, reshaping how pain in later life is conceptualized and managed and improving health and quality of life for older adults experiencing pain and disability. Her current NIH-funded R01 is a randomized controlled trial testing an innovative pain self-management intervention designed to address social determinants influencing chronic musculoskeletal pain in African Americans/Blacks.

A Fellow of the American Academy of Nursing, she has authored over 110 peer-reviewed publications and editorials, eleven book chapters, and delivered 140 scientific presentations. She is a distinguished scientist, nurse, and advocate. She served on the inaugural Board of Directors for the United States Association for the Study of Pain, helping to develop a new scientific organization in the U.S. Her exceptional contributions have been recognized with numerous honors, including the University of Florida Excellence Award for Assistant Professors—the first ever awarded to College of Nursing faculty—as well as the Southern Nursing Research Society’s Early Science Investigator Award, the IASP Pain in Older Persons SIG Junior Investigator Award, and the American Society for Pain Management Nursing® Excellence in Nursing Award for Pain Management of the Older Adult. Dr. Booker remains an influential leader and active member in several national and international pain, gerontology, and nursing organizations, where she continues to advance equity, innovation, and excellence in pain research, care, and education.

Fiona Talkington is a distinguished BBC radio presenter, best known for hosting the award-winning program Late Junction. She has presented live concerts from venues such as the Royal Albert Hall and Wigmore Hall and produced documentaries and talk shows for the BBC. Fiona holds a Master of Arts in Literature and the Visual Arts and a Master of Science in Creative Writing for Therapeutic Purposes (CWTP). She received the Royal Norwegian Order of Merit for her contributions to the arts and an honorary doctorate (D.Litt) from the University of Reading.  

Drawing on her personal experience with chronic neuropathic pain, Fiona serves as a patient partner in PAINSTORM and co-produces its podcast, PAINCAST.  

She has also participated in numerous SIGs for IASP and has facilitated numerous workshops for students and research groups with her focus on the communication and expression of chronic pain for individuals and in healthcare settingsand expression of chronic pain for individuals and in healthcare settings. In addition, Fiona has a forthcoming publication with Bloomsbury on the role of creative arts in enhancing communication between patients and clinicians. 

Harry Hebert is a Principal Investigator (Tenure Track) at the University of Dundee, specializing in chronic pain pharmacoepidemiology with a focus on neuropathic pain. He holds a BSc (Hons) in Genetics from the University of Nottingham (2009), an MSc in Human Molecular Genetics from Imperial College London (2010), and a PhD in Genetic Epidemiology from the University of Manchester (2015). Following his doctoral studies, Harry worked as a postdoctoral researcher in the Chronic Pain Research Group under Professors Blair H. Smith and Lesley Colvin at Dundee. Appointed to his current role in 2024, he leads the PAINSTORM Dundee study, funded by the Advanced Pain Discovery Platform (APDP), and conducts research into gabapentinoid reclassification in the UK and risk factors for mortality among individuals with chronic pain and substance use disorders. His career goal is to improve the lives of people living with chronic pain by leading research that influences clinical guidelines, policy, and practice. 

Jo Josh is a freelance communications professional specializing in translating medical and research information into plain language for mainstream audiences. Her background includes news and feature production for print and broadcast media, brand marketing, and crisis management. Since 2018, Jo has worked with the British HIV Association (BHIVA) on communications and advocacy with media, health systems, government, and HIV community organizations.  

She suffers from HIV-related peripheral neuropathy and edited language for “ACT OPEN,” a randomized controlled trial of online acceptance and commitment therapy for neuropathic pain in people living with HIV. In 2022, Jo provided plain language translations of research papers for IASP and is one of three patient partners for the PAINSTORM consortium (https://www.painstorm.co.uk), a three-year research project into the causes and mechanisms of neuropathic pain. She is a member of the Advanced Pain Discovery Platform (APDP).  

Jo’s roles include Data Safety Monitoring on the RIO study (bNAbs), CONNECT research into digital communications in sexual health, and patient communications for Surrey and Sussex Healthcare Trust as a member of its Council of Governors. She is a former Vice Chair of a NICE committee. 

Angelika Lampert, MD, is the Director of the Institute of Neurophysiology at RWTH Aachen University, Germany. She coordinates the Sodium Channel Network Aachen and serves as speaker of the Scientific Center for Neuropathic Pain Aachen (SCNAACHEN), focusing on inherited neuropathic pain syndromes such as small fiber neuropathy linked to sodium channel mutations. Her research emphasizes translational basic science, including patient-derived stem cells, Patch-Seq, sodium channel biophysics, and pharmacology. Angelika is co-chair of the IASP Global Year 2026 on Neuropathic Pain. 

Neil is Professor of Evidence-Based Healthcare in the Physiotherapy Division of the Department of Health Sciences. He previously worked as a musculoskeletal physiotherapist and now divides his time between teaching and research. Neil’s research focuses on evidence-based management of persistent pain, and he has published extensively in this area. He leads modules on clinical research methods and evidence-based practice for pre- and post-graduate clinicians. Neil served as Coordinating Editor for the Cochrane Pain, Palliative and Supportive Care (PaPaS) group from 2020–2023 and was a member of Cochrane’s central editorial board. He contributed to the UK NICE 2016 clinical guideline on low back pain and sciatica and currently chairs the IASP Methods, Evidence Synthesis and Implementation Special Interest Group (MESIGIG). Neil is Scientific Coordinator of the ENTRUST-PE network, supported by ERA-NET Neuron Cofund, and co-chair of the IASP Global Year 2026 on Neuropathic Pain. 

Andrew Rice is Professor of Pain Research at Imperial College London and President of the International Association for the Study of Pain (IASP). He earned his medical degree from St. Mary’s Hospital Medical School in 1982 and his research doctorate from St. Thomas’ Hospital Medical School in 1991. Andrew underwent specialist training in Oxford and at St Thomas’ Hospital before joining Imperial College in 1995. He led the Pain Research Group at Imperial College from its inception in 1995 until 2026. His research spans neuropathic pain in infectious diseases (HIV, Herpes Zoster, HTLV-1, leprosy), diabetic neuropathy, and peripheral nerve trauma and amputation, with a focus on improving translational research and evidence synthesis.  

Andrew chaired the IASP Presidential Task Force on Cannabis and Cannabinoid Analgesia and the Scientific Programme Committee for the 2020 World Congress on Pain. He previously served as an IASP Councilor and was elected President-Elect in 2022. Andrew is an Honorary Consultant in Pain Medicine at Chelsea and Westminster Hospital, stepping aside from clinical practice in 2023 to fulfill his presidential duties. 

http://www.imperial.ac.uk/people/a.rice

Dr. Mohammad Zunaid is an Assistant Professor in Bangladesh Civil Service under Ministry of Health & Family Welfare, Bangladesh. He holds an MBBS, BCS (Health), and MD in Anesthesiology. Mohammad was an IASP Pain Fellow at Siriaj Hospital, Bangkok, Thailand, and serves as a WFSA Mentor in Anaesthesia and Pain. He contributed to Pharmacotherapy and non-invasive neuromodulation for neuropathic pain: a systemic review and meta-analysis as a Co-author. He is a member of the IASP Membership & Chapter Committee and the Presidential Task Force for the Global Year 2027. 

Dr. Ru-Rong Ji is the William Maixner Professor of Anesthesiology and Director of the Center for Translational Pain Medicine at Duke University School of Medicine. He also holds professorships in Neurobiology, Cell Biology, and Immunology. Dr. Ji earned his PhD from the Shanghai Institute of Physiology, Chinese Academy of Sciences, and completed postdoctoral training at Peking University, the Karolinska Institute, and Johns Hopkins University. Prior to joining Duke, he served on the faculty at Harvard Medical School (MGH and BWH) for more than a decade. Dr. Ji has mentored over 100 scientists, many of whom now lead independent research laboratories worldwide. He serves on the editorial boards of Anesthesiology, Pain, Journal of Pain, Journal of Neuroscience, Journal of Clinical Investigation, and Physiological Reviews. His laboratory investigates GPCR- and glial cell–mediated signaling mechanisms underlying the development and resolution of pain.

Dr. Donald Iain MacDonald is a postdoctoral fellow in the Sensory Cells and Circuits Lab at the National Center for Complementary and Integrative Health (NCCIH), National Institutes of Health (NIH). He graduated from the University of Oxford in 2015 with a B.A. in Cell and Systems Biology, and then earned a Ph.D. in Neuroscience from University College London in 2020, supervised by Prof. John Wood. He came to the NIH in 2021 to work with Dr Alex Chesler and is currently investigating how nociceptors use different neuropeptides to control pain and inflammation. His work is supported by a Branco Weiss Fellowship and a HEAL Initiative Pathway to Independence Award (K99/R00).

Dr. Bradley K. Taylor is a Professor at the Department of Anesthesiology & Perioperative Medicine and the Center for Neuroscience at the University of Pittsburgh, and the Pittsburgh Center for Pain Research. He completed his PhD at the University of California, San Diego, and his postdoctoral training with Dr. Allan Basbaum at the University of California, San Francisco. Dr. Taylor is the recipient of the NIH First Independent Research Support and Transition Award and the NIH Independent Scientist Award K02 from NIDA. His research area involves studying neuropeptidergic NPY mechanisms of chronic pain, underlying mechanisms of acute to chronic pain transition, as well as understanding the molecular neurobiology of pain sensitization and opioid dependence. His work has been continuously funded by the NIH since 1999 and includes a history of multiple R01s as Principal Investigator. He has published over 120 peer-reviewed research and review articles, including senior-author articles in Science and Nature. He is also serving on the editorial boards of several high-impact journals, chaired numerous symposia at domestic and international meetings, and served on dozens of NIH study sections.

Dr. Paramita Basu earned her Ph.D. in Molecular Biology from Texas Woman’s University (TWU), where she trained under the mentorship of Drs. Dayna L. Averitt and Camelia Maier. Her doctoral research focused on identifying novel phytochemicals from the Texas native plant Euphorbia bicolor with potential as non-opioid therapeutics for pain management. Following completion of her Ph.D., Dr. Basu joined the Department of Anesthesiology and Perioperative Medicine at the University of Pittsburgh and the Pittsburgh Center for Pain Research as a postdoctoral fellow under the mentorship of Dr. Bradley K. Taylor. She was subsequently promoted to Research Assistant Professor within the same department. Dr. Basu’s current research is centered on elucidating the mechanisms underlying chronic postsurgical and neuropathic pain and identifying therapeutic strategies to mitigate chronic pain. She has authored original research articles, review papers, and book chapters, with publications appearing in journals including Anesthesiology, Journal of Neuroscience, JCI Insight, Pain Reports, European Journal of Pharmacology, Frontiers in Pharmacology, and Nutrients. Her work has been recognized with several honors, including the Society for Neuroscience Trainee Professional Development Award, the International Association for the Study of Pain Sex, Gender, Race, and Pain Special Interest Group Best Paper Award, and the U.S. Association for the Study of Pain Best Poster Presentation in Basic Science Award at its Annual Scientific Meeting. Dr. Basu currently serves as co-chair of the Acute to Chronic Pain Special Interest Group and as an early-career contributor to the Pain Research Forum. She also serves as an ad hoc reviewer for numerous biomedical science journals and as a review editor for Frontiers in Pain Research.

Dr. Davis is a senior scientist at the Krembil Brain Institute (University Health Network) and professor at the University of Toronto. Dr. Davis chaired the IASP presidential task force on the use of brain imaging to diagnosis pain and was co-editor of book Pain Neuroethics and Bioethics. She has served on the IASP Council, was a Mayday Fellow, was inducted into the Johns Hopkins Society of Scholars, Canadian Academy of Health Sciences, the Royal Society of Canada, and is a past President of the Canadian Pain Society. Dr. Davis currently serves as the Editor-in-Chief of PAIN.

Dr. Tonya Palermo is Professor of Anesthesiology and Pain Medicine at University of Washington and directs an interdisciplinary research center at Seattle Children’s Research Institute dedicated to advancing child and family health. Dr. Palermo has been in Seattle since 2010 where she leads the Pediatric Pain & Sleep Innovations Lab. She is a clinical pediatric psychologist. The focus of her research is on behavioral, psychosocial and family factors that affect pain experiences, the interrelationship of sleep and pain, and innovative psychological treatments for managing and preventing chronic pain. Currently, Dr. Palermo serves as Editor-in-Chief of the Journal of Pain. 

Dr. Vollert is a chronic pain researcher from Germany, where he did his PhD in neurophysiology at the University of Heidelberg. After six years at Imperial College in London,UK, he has joined the University of Exeter, UK, as a Lecturer (Assistant Professor) in October 2023.

His background is in data science and statistics, and he collaborates with clinicians across the UK and Europe to analyze multifaceted datasets searching for predictors of developing chronic pain (for example after surgery) and predicting response to treatment to enable personalized pain medicine. He uses a wide array of methods -sensory phenotyping, patient-reported outcomes, -omics – and machine learning to identify mechanistic subgroups.

Patrice Forget, MD PhD, is the clinical chair in anesthesia at the University of Aberdeen (UK), and an honorary consultant at the NHS Grampian. He was previously a clinical professor in Anesthesia and Pain Medicine in Belgium, and the president of the Belgian Pain Society. He is involved in clinical research, focused on mainly pain, perioperative epidemiology, and clinical pharmacology. Over the past few years, as a principal investigator and/or national coordinator, he has published more than 150 articles, letters, or editorials. He is also the chair of the PANDOS (Pain AND Opioids after Surgery) ESAIC Research Group (European Society of Anesthesiology and Intensive Care). 

Louise Trewern is a lived experience advocate who has contributed extensively to improving support for people living with persistent pain. She worked closely with Live Well With Pain, where she helped develop educational resources and shared insights from her own recovery after coming off high-dose prescription opioids. Her work supported others navigating opioid tapering, and she has been a strong advocate for better pain education for the public. Louise promotes self-management approaches that include healthy eating, gentle movement, and reconnecting with life beyond pain. She has served on a number of national committees, including the Physiotherapy Pain Association, and was Vice Chair of the British Pain Society’s Patient Voice Committee. She also contributed to the NICE Guideline Committee NG215 on Medicines Associated with Dependence or Withdrawal, and is a Fellow of the Wolfson Research Institute at Durham University.

Amy Donnelly, MD, a consultant anesthetist in St. Columcille’s Hospital and St. Vincent’s University Hospital in Dublin, Ireland. She obtained her CCST from the College of Anesthesiologists of Ireland in 2020, after which she completed a fellowship in anesthesia in Addenbrooke’s Hospital, Cambridge. She then undertook the first perioperative medicine fellowship in Ireland in St. Vincent’s. Amy is a board member of the Faculty of Pain medicine of Ireland for her work on opioid prescribing in acute pain. She was part of the HSE (Health Service Executive of Ireland) working group for prescribing opioids for acute non-cancer pain. She is currently the FPM board representative on the HSE working group for codeine. Amy was part of the multidisciplinary team involved in the BPS/IPS patient information leaflet on Managing Pain after Surgery.  

Felicia Cox, FRCN, is a nurse consultant in pain management. She is a past chair of the Royal College of Nursing (RCN) Pain and Palliative Care Forum and is a co-opted member of the Council of the British Pain Society. She is a committee member of the EFIC Covid Task Force and EFIC Research Strategy group, the IASP Acute Pain Special Interest Group, and a founding member of the Pain Nurse Network. She is the co-editor of the British Journal of Pain. The breadth of her pain-related publications spans the continuum from the Daily Telegraph to The Lancet with systematic reviews, chapters, and books in between. She has also co-authored e-learning modules on pain and medicine safety, and has contributed to several Family Practice Management publications. She is an honorary lecturer at King’s College London, UK, and has been awarded honorary membership of the British Pain Society and Fellowship of the RCN for her services to pain. Her clinical and research interests include chronic postsurgical pain and procedural pain, and enjoys supporting novice authors to publish and disseminate their work.